Quantcast
Home > Quotes > EW

Edwards Lifesciences Corporation Common Stock (EW) Quote & Summary Data

EW 
$194.33
*  
1.25
0.65%
Get EW Alerts
*Delayed - data as of Jul. 19, 2019  -  Find a broker to begin trading EW now
Exchange:NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
195
Today's High / Low
$ 195.24 / $ 193.13
Share Volume
1,305,828
90 Day Avg. Daily Volume
1,343,554
Previous Close
$ 193.08
52 Week High / Low
$ 197.86 / $ 134.53
Market Cap
40,387,526,751
P/E Ratio
54.13
Forward P/E (1y)
36.50
Earnings Per Share (EPS)
$ 3.59
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.2

Intraday Chart

Shares Traded

Share Volume:
1,305,828
90 Day Avg. Daily Volume:
1,343,554

P/E Ratio

P/E Ratio:
54.13
Forward P/E (1y):
36.50
Earnings Per Share (EPS):
$ 3.59

Trading Range

The current last sale of $194.33 is 44.45% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 195.24 $ 197.86
 Low: $ 193.13 $ 134.53

ETFs with EW as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.46% iShares U.S. Medical Devices ETF (IHI) +19.82 (8.77%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Edwards Lifesciences Corporation is the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world's leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring during surgery or in intensive care. Edwards Lifesciences has a proud six-decade history as a leader in these areas. Since our founder, Lowell Edwards, first dreamed of using engineering to address diseases of the human heart, we have steadily built a company on the premise of imagining, building, and realizing a better future for patients. A pioneer in the development of heart valve therapies, we are the world's leading manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve.  ... More ...  



Risk Grade

Where does EW fit in the risk graph?


Risk Grade Scale



Consensus Recommendation

Analyst Info